Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE GmbH, Germany, Distributed by Hikma Berkeley Heights, NJ 07922, NDC 0143-9299-01
Published January 4, 2023 · Recall initiated: December 16, 2022
Summary
FDA records drug Class II recall D-0090-2023, published January 4, 2023 and initiated December 16, 2022. Recalling firm: Hikma Pharmaceuticals USA Inc.; Status: Terminated; Reported quantity: 13,760 vials; Lot: Lot#: BQ0006, Exp 08/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.
What to do
Voluntary: Firm initiated
Get an email if GANCICLOVIR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GANCICLOVIR
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Distributor
- USA Nationwide
- Lot
- Lot#: BQ0006, Exp 08/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGlycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKAREJanuary 4, 2023
- FDAAlcohol Antiseptic 80% Topical Solution Hand Sanitizer, Non-Sterile Solution, packaged as a a) 2.5 gallonJanuary 4, 2023
- FDATimolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario CanadaJanuary 4, 2023
- FDARevaclear 400 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.December 28, 2022
- FDARevaclear 300 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.December 28, 2022
- FDAVivid S6 ultrasound. Used in ultrasound imaging and analysis in Fetal/Obstetrics; Abdominal/GYN; Pediatric;December 28, 2022
Questions about this recall
Was Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE GmbH, Germany, Distributed by Hikma Berkeley Heights, NJ 07922, NDC 0143-9299-01 recalled?
Yes. FDA published recall D-0090-2023 on January 4, 2023. Reported hazard: Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GANCICLOVIR.